The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 08, 2020
Filed:
Jan. 11, 2017
Applicants:
Centre National DE LA Recherche Scientifique (Cnrs), Paris, FR;
Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;
Universite Paris Descartes, Paris, FR;
Inventors:
Sandrine Bourdoulous, Gagny, FR;
Camille Faure, Paris, FR;
Assignees:
Primary Examiner:
Int. Cl.
CPC ...
C07D 335/20 (2006.01); A61K 31/41 (2006.01); A61K 31/497 (2006.01); A61P 35/00 (2006.01); C07D 275/04 (2006.01); C07D 279/24 (2006.01); C07D 293/12 (2006.01); C07D 405/06 (2006.01); C07D 409/06 (2006.01);
U.S. Cl.
CPC ...
C07D 335/20 (2013.01); A61K 31/41 (2013.01); A61K 31/497 (2013.01); A61P 35/00 (2018.01); C07D 275/04 (2013.01); C07D 279/24 (2013.01); C07D 293/12 (2013.01); C07D 405/06 (2013.01); C07D 409/06 (2013.01);
Abstract
The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.